A Chief Regulatory Officer has given you a budget line and a deadline: by the end of the fiscal year, the submission writing function will have a defensible AI stack, validated, governed, and ready to survive a Pre-Approval Inspection. Six vendors are on the shortlist, each with a polished demo and a reference customer who will say warm things on a call. Veeva will show you Vault RIM AI Agents that plan a submission and draft correspondence. Certara will show you CoAuthor drafting a Module 2.5 paragraph that reads like a senior writer wrote it. Phlex, Narrativa, Deep Intelligent Pharma, and Cortellis will each show you something that looks like the future. The trap is that every one of these demos is true, and none of them answers the question you are actually accountable for, which is not "which tool is best" but "which combination of capabilities, under what validation posture, with what exit options, gives this function a stack it can defend to a Quality Council and to an FDA inspector for the next five years." This lesson builds the decision matrix that answers that question, and it does so vendor-neutrally on purpose, because the single most expensive mistake a function strategist can make is to architect a stack that cannot survive the loss of any one vendor in it.

Why the Stack Is the Unit of Analysis, Not the Tool

The instinct of a function under pressure is to run a bake-off, score the vendors, and pick a winner. That instinct is wrong, and understanding why is the foundation of everything that follows. A submission is not produced by one tool; it is produced by a chain of capabilities that must interlock: submission planning and content planning, correspondence and meeting-package drafting, Module 2 narrative generation, eCTD assembly and validation, reference and citation quality control, and regulatory intelligence feeding the whole thing. No single vendor does all of these at the depth a major sponsor needs, and any vendor that claims to is asking you to bet the function on a monoculture. The unit of analysis is therefore the stack, the assembled set of capabilities and the interfaces between them, and the strategist's job is to architect that stack so that each capability is sourced from a vendor strong in it, integrated through interfaces you control, and replaceable without re-architecting the whole. The decision matrix that follows scores capability categories first and vendors second, because a vendor is only ever a current best instance of a capability you will still need long after that vendor's roadmap diverges from yours.

This framing has a second consequence that senior leaders often miss. The most important property of a stack is not the peak capability of its best component; it is the validation and integration coherence of the whole. A function that buys the most powerful Module 2 drafting engine on the market and bolts it onto an eCTD process it cannot trace has not improved its submission quality; it has added an un-validated content source upstream of a regulated record. The matrix weights integration posture and validation posture as heavily as raw capability for exactly this reason, and a function strategist who lets a dazzling demo override that weighting will spend the next two years explaining to the Quality Council why the dazzling tool is the one the inspector flagged.

The Six-Axis Decision Matrix

Score every candidate capability and every vendor instance of it against six axes, and weight the axes to your function's risk posture rather than to the vendor's marketing. The first axis is scope: what part of the submission chain does this capability actually cover, and where are its hard edges? A tool that drafts Module 2.5 narrative but cannot ingest the final TLF package has a scope edge precisely where the highest-risk verification work lives, and that edge is a cost you will pay in human hours forever. The second axis is integration: does the capability expose stable, documented interfaces into your system of record, your eCTD pipeline, and your audit trail, or does it require copy-paste handoffs that break traceability? Integration is where most stacks quietly fail, because a capability that cannot write its provenance into your audit trail turns every output into an un-attributable record under ALCOA+.

The third axis is validation posture: does the vendor ship validation documentation, an intended-use statement, a controlled release cadence, and a change-notification process that lets you maintain a validated state, or does it push silent model updates that invalidate your qualification overnight? The fourth axis is IP protection: what is the data-handling contract? You need, at minimum, a Business Associate Agreement where applicable, a zero-data-retention or no-training-on-your-data guarantee for any Commercial Confidential Information and trade-secret content, and a clear statement of where the inference runs. The fifth axis is exit options: if this vendor is acquired, raises prices, falls behind, or fails, how do you get your content, your configurations, your prompts, and your audit history out, and how long does the migration take? The sixth axis is regulatory alignment: how does the vendor's posture map to the FDA-EMA Guiding Principles, to 21 CFR Part 11 and EU Annex 11, and to GAMP 5 software categorization, and will the vendor support you in an inspection? Score each axis one to five, weight them, and the matrix produces not a winner but a portfolio: which capabilities to buy, from whom, and which to keep dual-sourced.

The System-of-Record Anchor: Veeva Vault RIM AI Agents

Most large sponsors already run a regulatory information management system of record, and for a large share of the market that is Veeva Vault RIM. This pre-existing footprint changes the evaluation, because the RIM AI Agents that reached general availability on the August 2026 Vault release sit inside the system where your submission planning, correspondence, and dossier metadata already live. As a capability category, what this represents is system-of-record-native agentic assistance: submission planning, correspondence and meeting-package drafting, and dossier-preparation support that can read and write the structured RIM data directly, which is an enormous integration advantage on the second matrix axis. The strategic temptation, and the trap, is to conclude that because the agents live in your system of record, the stack question is settled. It is not. System-of-record-native agents are exceptional at the structured, metadata-bound parts of the workflow and are deliberately conservative about the unstructured narrative-generation work where the highest factual risk lives, which means they answer the integration axis brilliantly and leave the scope axis for Module 2 narrative substantially open.

Treat the RIM AI Agents as the anchor capability around which the rest of the stack is composed, not as the stack. Their value on the integration and validation axes is genuine and hard for a point solution to match, because provenance and audit-trail writing come for free when the agent lives in the record. But the function strategist must hold two disciplines here. First, the August 2026 release cadence is a planning input, not a dependency: align your validation and rollout to it, but never let a single vendor's release schedule become the critical path of your function's AI capability, because that is precisely the monoculture risk the whole matrix exists to prevent. Second, even a system-of-record-native agent is a configured-to-custom GAMP 5 artifact whose updates can change behavior, so the validation-posture axis applies to it with full force, and "it is in Vault" is not a substitute for an intended-use statement and a change-control process you own.

The Narrative Engines: Certara CoAuthor, Narrativa, Deep Intelligent Pharma

The capability category that the system-of-record anchor deliberately leaves open is regulated narrative generation, the drafting of Module 2 summaries, CSR sections, and regulatory documents where prose fidelity to source data is the entire game. Certara CoAuthor, which joined the Veeva AI Partner Program in October 2025 with a CoAuthor-to-Vault RIM integration announced at that time and production rollouts in progress across sponsors through 2026, is a leading instance of this category, alongside Narrativa's regulatory document generation and Deep Intelligent Pharma's integrated submission AI. What you are evaluating in this category is not whether the tool can write a fluent Module 2.5.4 paragraph, because they all can; you established in Level 1 that fluency is decoupled from truth. What you are evaluating is the grounding architecture: does the engine cite the source document for every factual claim, refuse to invent reference numbers, flag missing data rather than fill it, and write its provenance into an audit trail you can reconcile? A narrative engine with weak grounding is not a productivity tool; it is a fabricated-cross-reference generator pointed at your most scrutinized artifact.

The integration axis is decisive in this category and is where the Partner Program relationships matter. A narrative engine that integrates natively with your RIM system of record can pull the correct, current source content into its context and write the resulting draft and its provenance back under change control, which is the difference between an accelerant and a liability. An engine that requires copy-paste from the system of record into a separate tool and back breaks the audit trail at exactly the moment a Day 74 Information Request will probe. The function strategist's discipline in this category is to insist on dual-sourceability as a design principle even when one engine is clearly ahead today: name the capability "regulated narrative generation," qualify at least one primary and keep a credible secondary in your validation pipeline, and structure the integration so the narrative engine is a replaceable component feeding your pipeline rather than the pipeline itself. The reason is not vendor paranoia; it is that this is the fastest-moving category in the stack, and the leader today is not guaranteed to be the leader when your next BLA locks.

The Assembly and Validation Layer: Phlex eSolutions and eCTD Quality Control

Downstream of narrative generation sits a capability category that demos rarely glamorize but inspections always probe: eCTD assembly, publishing, and structural validation. Phlex eSolutions with its eCTDXPress publishing capability and the broader Phlexglobal eTMF footprint is a named instance here, and the eCTD validation function long associated with Certara's Pinnacle 21 sits adjacent to it. This layer is where AI-generated content becomes a regulated submission record, and it is therefore where the integration and validation axes carry the most weight. The strategic point is that an error introduced by a narrative engine upstream, an invented Table 14.2.1.4 cross-reference, a mis-granularized section, a Module 2.3 fragment that belongs in Module 3.2.S.4, is caught, if it is caught at all, in this layer's reference and granularity quality control. A function that invests heavily in narrative generation and underinvests in the assembly-and-validation layer has built a fast pipeline that ships its own errors faster.

Evaluate this layer for its ability to act as the structural backstop to the AI-generated content above it. The questions are concrete: does the publishing and validation capability run reference quality control that can detect a cross-reference whose target does not exist, not merely one whose format is invalid? Does it enforce eCTD v4.0 granularity and flag mis-placed content? Does it write a validation record into the audit trail that an inspector can read? On the matrix, this layer typically scores high on validation posture, because publishing and validation tools have lived inside Part 11 expectations for years and are built to be qualified, and that maturity is an asset you should weight accordingly. The exit-options axis matters here too but differently: the eCTD standard itself is the portability guarantee, so a function that keeps its content in standard structured form retains the ability to change publishing vendors without re-authoring, which is a structural exit option the narrative layer does not enjoy.

The Intelligence Layer: Cortellis and the Input Side of the Stack

The matrix so far has scored the tools that produce and assemble the submission, but a submission strategy is only as good as the intelligence feeding it, and that is a distinct capability category with its own evaluation. Cortellis from Clarivate is the named instance of regulatory and competitive intelligence: the landscape data, precedent analysis, and regulatory-intelligence feeds that inform what you file, when, and how you position it. The reason this belongs in the same matrix as the drafting and publishing tools is that an AI-augmented submission function increasingly wants this intelligence flowing into the same context as the drafting: precedent for a Type C meeting position, competitive landscape for a benefit-risk framing, regulatory-intelligence signals that shape the submission plan the RIM agents then execute. Evaluate the intelligence layer on data provenance and freshness above all, because an intelligence feed that is stale or whose sourcing you cannot trace is worse than no feed when it shapes a position you will defend to a regulator.

The integration question in the intelligence layer is whether the feed can be grounded into your other tools' context safely, which raises the same IP-protection discipline from the other direction. When competitive intelligence and regulatory precedent flow into a narrative engine's context alongside your own Commercial Confidential Information, the data-handling contract must hold for both, and the function strategist must ensure that no third-party intelligence content contaminates the provenance of your regulated record. Score the intelligence layer on the IP and integration axes with particular care, treat it as a grounding input rather than a content generator, and keep it architecturally separable, because intelligence vendors and content vendors fail and re-price on different schedules and you do not want one renewal negotiation to hold the whole stack hostage.

Composing the Stack and the Do-Not-Depend-on-One-Vendor Rule

With all six capability categories scored, the strategist composes the portfolio, and the composition rule is explicit: no single vendor may be a single point of failure for the function's ability to produce a submission. This is not an ideological stance; it is a continuity-of-operations and inspection-readiness requirement. Concretely, it means three things. First, for every capability category, you can name the exit path: how content, configurations, and audit history leave the vendor, and how long re-qualification of an alternative would take. Second, for the fastest-moving and highest-risk category, regulated narrative generation, you keep a credible secondary in your validation pipeline rather than fully committing to one engine, so that a vendor's acquisition, price shock, or quality regression does not stop your function. Third, the interfaces between layers are specified and owned by you, so that any single layer is a replaceable component rather than load-bearing structure, which is the architectural expression of the whole vendor-neutral discipline.

The defense of this stack to a Quality Council or an inspector then writes itself, because the architecture is the argument. You do not claim the AI is trustworthy; you demonstrate a stack in which every capability is sourced from a qualified vendor, integrated through owned and audited interfaces, validated under a posture you control, contractually protected for IP, and replaceable without re-architecting. You map each capability to the FDA-EMA Guiding Principles it most engages, governance and documentation for the whole, fitness for purpose for each engine, accountability anchored in the named human author at every output. And you state plainly the discipline that the rest of this chapter and the validation chapter operationalize: the function depends on no single vendor, the August 2026 Vault cadence and every other vendor's roadmap are planning inputs rather than dependencies, and the value of the stack is the coherence of the validated whole, not the peak capability of its most impressive demo.

Key Takeaways

• The stack, not the tool, is the unit of analysis, and integration and validation coherence matter more than the peak capability of the best component. A submission is produced by a chain of capabilities that must interlock, so the strategist scores capability categories first and vendors second, treating each vendor as the current best instance of a capability the function will still need long after that vendor's roadmap diverges.
• Score every capability and vendor on six axes: scope, integration, validation posture, IP protection, exit options, and regulatory alignment. The matrix produces a portfolio rather than a winner, telling you which capabilities to buy, from whom, and which to keep dual-sourced, weighted to your function's risk posture rather than to vendor marketing.
• Use the system-of-record-native agentic layer, such as Veeva Vault RIM AI Agents, as the anchor, not the stack, and treat the August 2026 release cadence as a planning input rather than a dependency. System-of-record agents win the integration axis because provenance comes for free, but they deliberately leave Module 2 narrative generation open, and they remain configured-to-custom GAMP 5 artifacts whose updates demand a validation posture you own.
• For regulated narrative generation, evaluate grounding architecture and integration over fluency, and keep the category dual-sourced. Engines like Certara CoAuthor, Narrativa, and Deep Intelligent Pharma all write fluent prose, so the real test is whether they cite sources, refuse to invent references, flag missing data, and write provenance into an audit trail, and because this is the fastest-moving category, the leader today is not guaranteed to lead when your next BLA locks.
• Compose the portfolio so no single vendor is a single point of failure: name every exit path, own every interface, and let the architecture be the inspection defense. The assembly-and-validation layer such as Phlex eSolutions is the structural backstop that catches upstream AI errors, the intelligence layer such as Cortellis is a grounding input kept architecturally separable, and the whole stack maps to the FDA-EMA principles with accountability anchored in the named human author at every output.